1. Home
  2. PROF vs NRO Comparison

PROF vs NRO Comparison

Compare PROF & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • NRO
  • Stock Information
  • Founded
  • PROF N/A
  • NRO 2003
  • Country
  • PROF Canada
  • NRO United States
  • Employees
  • PROF N/A
  • NRO N/A
  • Industry
  • PROF Medical/Dental Instruments
  • NRO Finance/Investors Services
  • Sector
  • PROF Health Care
  • NRO Finance
  • Exchange
  • PROF Nasdaq
  • NRO Nasdaq
  • Market Cap
  • PROF 134.3M
  • NRO 156.7M
  • IPO Year
  • PROF N/A
  • NRO N/A
  • Fundamental
  • Price
  • PROF $4.11
  • NRO $3.28
  • Analyst Decision
  • PROF Strong Buy
  • NRO
  • Analyst Count
  • PROF 1
  • NRO 0
  • Target Price
  • PROF $11.00
  • NRO N/A
  • AVG Volume (30 Days)
  • PROF 167.1K
  • NRO 239.4K
  • Earning Date
  • PROF 11-06-2025
  • NRO 01-01-0001
  • Dividend Yield
  • PROF N/A
  • NRO 11.41%
  • EPS Growth
  • PROF N/A
  • NRO N/A
  • EPS
  • PROF N/A
  • NRO N/A
  • Revenue
  • PROF $11,840,000.00
  • NRO N/A
  • Revenue This Year
  • PROF $60.07
  • NRO N/A
  • Revenue Next Year
  • PROF $121.80
  • NRO N/A
  • P/E Ratio
  • PROF N/A
  • NRO N/A
  • Revenue Growth
  • PROF 59.81
  • NRO N/A
  • 52 Week Low
  • PROF $3.90
  • NRO $2.51
  • 52 Week High
  • PROF $9.17
  • NRO $3.45
  • Technical
  • Relative Strength Index (RSI)
  • PROF 30.34
  • NRO 55.48
  • Support Level
  • PROF $4.38
  • NRO $3.20
  • Resistance Level
  • PROF $4.69
  • NRO $3.34
  • Average True Range (ATR)
  • PROF 0.21
  • NRO 0.04
  • MACD
  • PROF -0.03
  • NRO 0.00
  • Stochastic Oscillator
  • PROF 11.04
  • NRO 53.57

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").

Share on Social Networks: